Molecule intelOpportunity: Lower0

Tartaric Acid

26 brands · 20 companies · product forms

Opportunity snapshot

Launch attractiveness
10
Market saturation
52
Price room
2
Regulatory risk
0
26
brands
20
companies
Rs 31
median price
3
price points
1.08x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 12%

Price room

Across observed sources and strengths
CheapestRs 28.6
MedianRs 31
Most expensiveRs 31
Spread1.08×
Sources: DVAGO, Servaid

max/min price ratio 1.08x across 3 trusted points (Rs 28.6-31.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(2) + 20% low-competition(48) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

20 canonical companies and 26 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 1.08x across 3 trusted points (Rs 28.6-31.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.